why choose us

Clinical Trials Search

Showing 16,110 of 132,963 result(s)
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions:

Date: 2023-01-20

A Study Evaluating AHB-137 in Healthy Participants and Participants With Chronic Hepatitis B

Status: Completed

Condition: Chronic Hepatitis B

Interventions: AHB-137 will be administered

Date: 2023-01-20

Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis

Status: NOT_YET_RECRUITING

Condition: Osteomyelitis of Jaw

Interventions: Oral antibiotic used based on indication

Date: 2023-01-20

Dietary Reporting In The Amyloidoses

Status: Completed

Condition: Amyloidosis

Interventions: Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal;alternative supplements in from week 2-9.
P

Date: 2023-01-20

COACH-Cog Intervention Adaptation Focus Groups

Status: ACTIVE_NOT_RECRUITING

Condition: Focus Groups

Interventions:

Date: 2023-01-20

The Actuate-CBC Study

Status: Completed

Condition: Telemedicine

Interventions: The study team will develop and design key elements of the implementation intervention (toolkit) among a small group of burn and non-burn clinician st

Date: 2023-01-20

Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

Status: Completed

Condition: Pneumocystis Jirovecii Infection

Interventions:

Date: 2023-01-20

Pilot Study of Nivolumab w;Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Status: Completed

Condition: Metastatic Melanoma

Interventions: Nivolumab is a monoclonal antibody o PD-1 protein, which is normally express on the surface of activated T cells.
The interaction of PD-1 with it

Date: 2023-01-20

Immunomodulatory Effects of PCSK9 Inhibition

Status: NOT_YET_RECRUITING

Condition: Atherosclerotic Cardiovascular Disease

Interventions: Allows for non-invasive assessment of atherosclerotic plaque burden and morphology

Date: 2023-01-20

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Status: Completed

Condition: Primary Ciliary Dyskinesia

Interventions: RCT1100 mRNA therapy supplied as varying dose strengths administered via oral inhalation using nebulizer

Date: 2023-01-20